Corporate
Agios Wins Historic FDA Approval: AQVESME Becomes First Oral Therapy for Broad Thalassemia Population
Dec 24, 2025
You're signed outSign in or to get full access.
AGIOS PHARMACEUTICALS (AGIO) Earnings Call Transcripts
Browse quarterly earnings call transcripts for AGIOS PHARMACEUTICALS.
Q3 2025
Oct 30, 2025
Q2 2025
Jul 31, 2025
Q1 2025
May 1, 2025
Q4 2024
Feb 13, 2025
Q3 2024
Oct 31, 2024
Q2 2024
Aug 1, 2024
Q1 2024
May 2, 2024